In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke.
Where this comes from
- Record sourced from PubMed, PMID 35226525.
- Also identified by DOI 10.7326/J22-0008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Wang Y, Meng X, Wang A, et al. <b>Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA.</b> N Engl J Med. 2021;385:2520-30. 34708996.
Medical subject headings
- Ischemic Attack, Transient
- Stroke